Clinical Trials Browser

Completed × INDUSTRY × tomivosertib × Clear all

NCT03616834 2023-03-22

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

Phase 2 Completed

Other solid neoplasm

Solid Tumors

NCT03258398 2019-07-18

A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms